Tag Archives: healthcare

No 'One Drug Per Therapeutic Class' for Congress

by Tom Norton As many of you may recall, earlier this year I commented on a section of the new Obamacare law that directed Members of Congress and their staffs to participate in the new healthcare program, effective January 1, 2014.  The theory was that if Congress mandated Obamacare for all Americans, then Members of […]
Posted in Guest Blog, healthcare, Legal, Regulatory, Strategy | Also tagged , , , , , , , , | Leave a comment

Into the Extrapolation Machine: How We Joined the Elite 58%

By Les Funtleyder. The problem we see with the polarity of views is that both sides seem to be cranking up the extrapolation machine and use single studies/data points to draw broad conclusions to gin up opinions about ACA’s success or lack thereof. With respect to investing, uncertainly caused by media/pundit noise often depresses valuations […]
Posted in Guest Blog, healthcare, Op-Ed | Also tagged , , , , , , , , , | Leave a comment

Congress 'Tip Toes' Around Obamacare

by Tom Norton Of the many issues involved with the actual implementation of the 2010 Affordable Care Act, aka, “Obamacare”, few are more intriguing to me than those that personally impact Members of Congress (MOCs).  Here’s a good example of what I’m talking about — Today, on Capitol Hill, MOCs, along with thousands of their […]
Posted in Guest Blog, healthcare, Legal, Strategy | Also tagged , , , , , , , | 3 Comments

Saving Greece's Healthcare System: A Harbinger for Europe?

A just-published report from the European taskforce trying to help Greece crawl out of its crisis makes clear just how significant a role health reform is supposed to play in restoring health to the economy. It is, in a very acute form, a harbinger of what is around the corner for the other countries of […]
Posted in Europe, Global, Guest Blog, healthcare | Also tagged , , , , , | Leave a comment

Drug Reimbursement and the "New Medicaid"

by Tom Norton A lot has been written about the “state option” created by the Supreme Court ruling on HCR, and what it means to American medicine. Sorting out an opinion will, to a degree, depend on whom you read and what you believe. But regardless of where you come out on this issue, there […]
Posted in Guest Blog, healthcare, Legal, Market Access, R&D, Regulatory | Also tagged , , , , , , , | 1 Comment
  • Categories

  • Meta